DE69125969D1 - Arzneimittel zur Behandlung zentraler neuro-degenerativer Erkrankungen - Google Patents

Arzneimittel zur Behandlung zentraler neuro-degenerativer Erkrankungen

Info

Publication number
DE69125969D1
DE69125969D1 DE69125969T DE69125969T DE69125969D1 DE 69125969 D1 DE69125969 D1 DE 69125969D1 DE 69125969 T DE69125969 T DE 69125969T DE 69125969 T DE69125969 T DE 69125969T DE 69125969 D1 DE69125969 D1 DE 69125969D1
Authority
DE
Germany
Prior art keywords
medicines
treatment
neurodegenerative diseases
central neurodegenerative
central
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69125969T
Other languages
English (en)
Other versions
DE69125969T2 (de
Inventor
Toshio Tatsuoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of DE69125969D1 publication Critical patent/DE69125969D1/de
Application granted granted Critical
Publication of DE69125969T2 publication Critical patent/DE69125969T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
DE69125969T 1990-06-06 1991-02-28 Arzneimittel zur Behandlung zentraler neuro-degenerativer Erkrankungen Expired - Fee Related DE69125969T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14770990 1990-06-06

Publications (2)

Publication Number Publication Date
DE69125969D1 true DE69125969D1 (de) 1997-06-12
DE69125969T2 DE69125969T2 (de) 1997-09-25

Family

ID=15436447

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69125969T Expired - Fee Related DE69125969T2 (de) 1990-06-06 1991-02-28 Arzneimittel zur Behandlung zentraler neuro-degenerativer Erkrankungen

Country Status (6)

Country Link
US (1) US5155129A (de)
EP (1) EP0460358B1 (de)
JP (1) JP3089040B2 (de)
CA (1) CA2037188A1 (de)
DE (1) DE69125969T2 (de)
HU (1) HUT57583A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401850A (en) * 1990-06-06 1995-03-28 Suntory Limited Cyclopropachromen derivatives
JP3993651B2 (ja) * 1994-10-21 2007-10-17 アスビオファーマ株式会社 シクロプロパクロメンカルボン酸誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0723367B2 (ja) * 1986-02-27 1995-03-15 サントリー株式会社 オキサビシクロヘプタン誘導体

Also Published As

Publication number Publication date
JPH04235127A (ja) 1992-08-24
HUT57583A (en) 1991-12-30
US5155129A (en) 1992-10-13
JP3089040B2 (ja) 2000-09-18
EP0460358A2 (de) 1991-12-11
EP0460358B1 (de) 1997-05-07
DE69125969T2 (de) 1997-09-25
EP0460358A3 (en) 1992-10-07
HU910677D0 (en) 1991-09-30
CA2037188A1 (en) 1991-12-07

Similar Documents

Publication Publication Date Title
DE69315257D1 (de) Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen
DE69630479D1 (de) Arzneimittel zur Behandlung von entzündlichen Herzkrankheiten
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
DE3775805D1 (de) Arzneimittel zur behandlung periodontaler erkrankungen.
NO971816L (no) Farmasöytisk blanding for behandling av sykdommer forårsaket av IL-6 produksjon
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
KR920701466A (ko) 면역조절 장애 치료를 위한 제약학적 생성물
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
DE69600983D1 (de) Kapselpräparate zur Behandlung von Pflanzen
NO833279L (no) Farmasoeytiske preparater for behandling av uoensket sammenvoksing
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DK101197A (da) Medikament til behandling af thrombocytopenia
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
DE69125969T2 (de) Arzneimittel zur Behandlung zentraler neuro-degenerativer Erkrankungen
DK10188D0 (da) Middel til behandling af virussygdomme
DE69840432D1 (de) Arzneimittel zur behandlung der augen
EP0457671A3 (en) Dipyridamide for the treatment of diseases of the central or peripheral nervous system
PT84996A (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen
FI102810B1 (fi) Aine eläimen ihon käsittelyyn
DE19775036I2 (de) Arzneimittel zur Behandlung von Augenentzündung.
ATE336282T1 (de) Katheter zur behandlung von prostaterkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee